Contrast-induced nephropathy: Pharmacological prophylaxis

C. Briguori, G. Marenzi

Research output: Contribution to journalArticle

Abstract

Contrast media-associated acute renal failure represents the third most common cause of in-hospital renal function deterioration after decreased renal perfusion and post-operative renal insufficiency. Although generally benign, this complication is associated with a mortality rate ranging from 3.8 to 64%, depending on the increase of creatinine concentration. Multiple drugs have been tested in an attempt to prevent this complication. Central to the pathophysiology of contrast-induced nephrotoxicity (CIN) is an alteration in renal hemodynamics. In an effort to reverse these hemodynamic changes, vasodilators and diuretics have been tested as prophylactic drugs. However, their effectiveness has not been confirmed. Recently, considerable interest has resulted from the initial positive data on the effectivess of prophylactic administration of antioxidant compounds, such as acetylcysteine and ascorbic acid. In this review, we focus on the effectiveness of pharmacologic therapies for preventing CIN.

Original languageEnglish
JournalKidney International
Volume69
Issue numberSUPPL. 100
DOIs
Publication statusPublished - 2006

Fingerprint

Pharmacology
Kidney
Hemodynamics
Acetylcysteine
Vasodilator Agents
Diuretics
Acute Kidney Injury
Pharmaceutical Preparations
Contrast Media
Ascorbic Acid
Renal Insufficiency
Creatinine
Perfusion
Antioxidants
Mortality
Therapeutics

Keywords

  • Complications
  • Contrast media
  • Kidney
  • Prevention

ASJC Scopus subject areas

  • Nephrology

Cite this

Contrast-induced nephropathy : Pharmacological prophylaxis. / Briguori, C.; Marenzi, G.

In: Kidney International, Vol. 69, No. SUPPL. 100, 2006.

Research output: Contribution to journalArticle

@article{d7179cc78fe3486ab418b062aa2f4fe8,
title = "Contrast-induced nephropathy: Pharmacological prophylaxis",
abstract = "Contrast media-associated acute renal failure represents the third most common cause of in-hospital renal function deterioration after decreased renal perfusion and post-operative renal insufficiency. Although generally benign, this complication is associated with a mortality rate ranging from 3.8 to 64{\%}, depending on the increase of creatinine concentration. Multiple drugs have been tested in an attempt to prevent this complication. Central to the pathophysiology of contrast-induced nephrotoxicity (CIN) is an alteration in renal hemodynamics. In an effort to reverse these hemodynamic changes, vasodilators and diuretics have been tested as prophylactic drugs. However, their effectiveness has not been confirmed. Recently, considerable interest has resulted from the initial positive data on the effectivess of prophylactic administration of antioxidant compounds, such as acetylcysteine and ascorbic acid. In this review, we focus on the effectiveness of pharmacologic therapies for preventing CIN.",
keywords = "Complications, Contrast media, Kidney, Prevention",
author = "C. Briguori and G. Marenzi",
year = "2006",
doi = "10.1038/sj.ki.5000372",
language = "English",
volume = "69",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "SUPPL. 100",

}

TY - JOUR

T1 - Contrast-induced nephropathy

T2 - Pharmacological prophylaxis

AU - Briguori, C.

AU - Marenzi, G.

PY - 2006

Y1 - 2006

N2 - Contrast media-associated acute renal failure represents the third most common cause of in-hospital renal function deterioration after decreased renal perfusion and post-operative renal insufficiency. Although generally benign, this complication is associated with a mortality rate ranging from 3.8 to 64%, depending on the increase of creatinine concentration. Multiple drugs have been tested in an attempt to prevent this complication. Central to the pathophysiology of contrast-induced nephrotoxicity (CIN) is an alteration in renal hemodynamics. In an effort to reverse these hemodynamic changes, vasodilators and diuretics have been tested as prophylactic drugs. However, their effectiveness has not been confirmed. Recently, considerable interest has resulted from the initial positive data on the effectivess of prophylactic administration of antioxidant compounds, such as acetylcysteine and ascorbic acid. In this review, we focus on the effectiveness of pharmacologic therapies for preventing CIN.

AB - Contrast media-associated acute renal failure represents the third most common cause of in-hospital renal function deterioration after decreased renal perfusion and post-operative renal insufficiency. Although generally benign, this complication is associated with a mortality rate ranging from 3.8 to 64%, depending on the increase of creatinine concentration. Multiple drugs have been tested in an attempt to prevent this complication. Central to the pathophysiology of contrast-induced nephrotoxicity (CIN) is an alteration in renal hemodynamics. In an effort to reverse these hemodynamic changes, vasodilators and diuretics have been tested as prophylactic drugs. However, their effectiveness has not been confirmed. Recently, considerable interest has resulted from the initial positive data on the effectivess of prophylactic administration of antioxidant compounds, such as acetylcysteine and ascorbic acid. In this review, we focus on the effectiveness of pharmacologic therapies for preventing CIN.

KW - Complications

KW - Contrast media

KW - Kidney

KW - Prevention

UR - http://www.scopus.com/inward/record.url?scp=33646160221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646160221&partnerID=8YFLogxK

U2 - 10.1038/sj.ki.5000372

DO - 10.1038/sj.ki.5000372

M3 - Article

VL - 69

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - SUPPL. 100

ER -